(Q44483210)

3 December 2017

Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS). (English)

1 reference

3 December 2017

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Jan Mareš

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Peter Turcani

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

12

Zsolt Illes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

17

Michael Linnebank

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

author name string

Ulf Baumhackl

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Tunde Csepany

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Adam Czaplinski

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Florian Deisenhammer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Tobias Derfuss

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Tanja H Fabjan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Siegrid Fuchs

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Alenka Horvath Ledinek

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Sasa Sega Jazbec

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Eleonora Klimova

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Samuel Komoly

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Egon Kurca

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Lubomir Lisy

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Lubica Prochazkova

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Rozsa Csilla

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Jarmila Szilasiova

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Pavel Stourac

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Radomir Talab

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Marta Vachova

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

David Vodusek

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Olga Zapletalova

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Thomas Berger

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Jana Lizrova Preiningerova

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Franz Fazekas

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

Eva Havrdova

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

language of work or name

1 reference

1 May 2013

1 reference

CNS Neuroscience & Therapeutics

3 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

page(s)

302-306

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

Employment in multiple sclerosis. Exiting and re-entering the work force

14 May 2020

cites work

1 reference

What drives quality of life in multiple sclerosis?

21 January 2018

1 reference

The use of 4-aminopyridine (fampridine) in demyelinating disorders.

21 January 2018

1 reference

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial.

21 January 2018

1 reference

Dose comparison trial of sustained-release fampridine in multiple sclerosis

21 January 2018

1 reference

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

21 January 2018

1 reference

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

21 January 2018

1 reference

Outcome measurement in multiple sclerosis: detection of clinically relevant improvement

21 January 2018

1 reference

Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).

21 January 2018

1 reference

Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis.

21 January 2018

1 reference

Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment

21 January 2018

1 reference

Status epilepticus associated with dalfampridine in a patient with multiple sclerosis.

21 January 2018

1 reference

Quantitative functional measures in MS: what is a reliable change?

21 January 2018

1 reference

12 December 2020

Epileptic seizures, cranial neuralgias and paroxysmal symptoms in remitting and progressive multiple sclerosis

1 reference

12 December 2020

Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability

1 reference

12 December 2020

Walking capacities in multiple sclerosis measured by global positioning system odometer

1 reference

12 December 2020

Extended-release bupropion induced grand mal seizures.

1 reference

12 December 2020

Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable

1 reference

12 December 2020

4-Aminopyridine improves clinical signs in multiple sclerosis

1 reference

12 December 2020

Effects of 4-aminopyridine in patients with multiple sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1111/CNS.12101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493348&resulttype=core&format=json

14 May 2020

1 reference